Next Article in Journal
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
Previous Article in Journal
Crosstalk Between Mammalian Antiviral Pathways
Previous Article in Special Issue
Biogenesis, Stabilization, and Transport of microRNAs in Kidney Health and Disease
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessFeature PaperReview

Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs

Department of Pathology and Laboratory Medicine, Western University, London, ON N6A5A5, Canada
*
Author to whom correspondence should be addressed.
Non-Coding RNA 2019, 5(1), 30; https://doi.org/10.3390/ncrna5010030
Received: 8 February 2019 / Revised: 16 March 2019 / Accepted: 18 March 2019 / Published: 22 March 2019
(This article belongs to the Special Issue Non-Coding RNA, Fibrogenesis, and Fibrotic Disease)
  |  
PDF [1168 KB, uploaded 26 March 2019]
  |  

Abstract

Management of chronic diabetic complications remains a major medical challenge worldwide. One of the characteristic features of all chronic diabetic complications is augmented production of extracellular matrix (ECM) proteins. Such ECM proteins are deposited in all tissues affected by chronic complications, ultimately causing organ damage and dysfunction. A contributing factor to this pathogenetic process is glucose-induced endothelial damage, which involves phenotypic transformation of endothelial cells (ECs). This phenotypic transition of ECs, from a quiescent state to an activated dysfunctional state, can be mediated through alterations in the synthesis of cellular proteins. In this review, we discussed the roles of non-coding RNAs, specifically microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), in such processes. We further outlined other epigenetic mechanisms regulating the biogenesis and/or function of non-coding RNAs. Overall, we believe that better understanding of such molecular processes may lead to the development of novel biomarkers and therapeutic strategies in the future. View Full-Text
Keywords: diabetic complications; epigenetics; lncRNAs; histone modifications; miRNAs; ECM alterations diabetic complications; epigenetics; lncRNAs; histone modifications; miRNAs; ECM alterations
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Biswas, S.; Chakrabarti, S. Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs. Non-Coding RNA 2019, 5, 30.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Non-Coding RNA EISSN 2311-553X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top